VALION BIO INC (VBIO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.77-1.07%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VBIO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | FY 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | 0.8 | 1.2 | 1.8 | 1.3 | — |
| Total Revenues | — | — | 0.8 | 1.2 | 1.8 | 1.3 | — |
| Cost of Revenues | — | — | 0.8 | 0.9 | 1.5 | 1.3 | — |
| Gross Profit | — | — | 0.0 | 0.3 | 0.3 | (0.0) | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | — | 4.8 | — | — | — | — | — |
| R&D Expenses | 6.7 | 3.1 | 1.3 | 1.7 | 1.7 | 0.9 | — |
| Operating Income | (16.9) | (7.9) | (5.7) | (8.2) | (10.1) | (5.6) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 0.1 | — | — | — | — | — |
| Interest & Investment Income | 0.1 | 0.0 | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (1.3) | (0.1) | 0.0 | 0.0 | 0.0 | (2.9) | — |
| EBT, Incl. Unusual Items | — | — | — | (8.2) | (10.1) | — | — |
| Earnings from Continuing Operations | — | (8.0) | — | — | — | — | — |
| Net Income | |||||||
| Net Income | (18.8) | (8.9) | (5.7) | (8.2) | (10.1) | (8.5) | — |
| Per Share | |||||||
| Basic EPS | (5.55) | (7.84) | (19.68) | (176.80) | (104.32) | (2.43) | — |
| Diluted EPS | — | — | (19.68) | (176.80) | (104.32) | (2.43) | — |
| Basic Weighted Avg Shares | 3.4 | 1.2 | 0.3 | 0.0 | 0.1 | 3.5 | — |
| Diluted Weighted Avg Shares | — | — | 0.3 | 0.0 | 0.1 | 3.5 | — |
| Supplemental | |||||||
| EBITDA | — | — | (5.7) | (8.2) | (10.1) | — | — |
| EBIT | (16.9) | (7.9) | (5.7) | (8.2) | (10.1) | (5.6) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.